Table 2.
Group A |
Group B |
Group C |
Group D |
Group E |
Group F |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Sibs | Cases | Sibs | Cases | Sibs | Cases | Sibs | Cases | Sibs | Cases | Sibs |
n = 17 | n = 3 | n = 17 | n = 4 | n = 5 | n = 3 | n = 23 | n = 18 | n = 24 | n = 9 | n = 8 | n = 17 |
48.6 | 0 | 93.5 | 1.0 | 61.4 | 153 | 409.3 | 3.5 | 135.4 | 3.8 | 529.9 | 5.3 |
33.3 | 0 | 54.0 | 0.9 | 6.9 | 0 | 23.0 | 3.2 | 42.2 | 3.8 | 78.0 | 3.7 |
6.5 | 0 | 19.1 | 0 | 1.4 | 0 | 8.7 | 1.5 | 21.5 | 2.5 | 5.6 | 3.2 |
1.8 | 4.8 | 0 | 0 | 7.7 | 0.7 | 11.5 | 0 | 1.6 | 1.9 | ||
1.7 | 3.9 | 0 | 6.2 | 0.6 | 3.1 | 0 | 0 | 0.8 | |||
0.8 | 3.2 | 3.3 | 0.3 | 2.6 | 0 | 0 | 0.2 | ||||
0.7 | 3.1 | 2.2 | 0 | 1.5 | 0 | 0 | 0 | ||||
0.6 | 0.6 | 1.7 | 0 | 0.1 | 0 | 0 | 0 | ||||
0.2 | 0.4 | 1.3 | 0 | 0.07 | 0 | 0 | |||||
0 | 0.4 | 1.0 | 0 | 0 | 0 | ||||||
0 | 0 | 0.2 | 0 | 0 | 0 | ||||||
0 | 0 | 0.2 | 0 | 0 | 0 | ||||||
0 | 0 | 0.1 | 0 | 0 | 0 | ||||||
0 | 0 | 0 | 0 | 0 | 0 | ||||||
0 | 0 | 0 | 0 | 0 | 0 | ||||||
0 | 0 | 0 | 0 | 0 | 0 | ||||||
0 | 0 | 0 | 0 | 0 | 0 | ||||||
0 | 0 | 0 | |||||||||
0 | 0 | ||||||||||
0 | 0 | ||||||||||
0 | 0 | ||||||||||
0 | 0 | ||||||||||
0 | 0 | ||||||||||
0 |
Genotype of group A: DQB1*0201-DRB1*03,DQB1*0302-DRB1*04; genotype of group B: DQB1*0201-DRB1*03,DQB1*0201-DRB1*03; genotype of group C: DQB1*0302-DRB1*04,DQB1*0302-DRB1*04; genotype of group D: DQB1*0201-DRB1*03,X; genotype of group E: DQB1*0302-DRB1*04,X; genotype of group F: X,X. X is any haplotype other than DQB1*0201-DRB1*03 or DQB1*0302-DRB1*04; Cases, type 1 diabetics; Sibs, unaffected siblings.